Get startedLog in
    Picture of Bristol-Myers Squibb logo

    CELG RT — Bristol-Myers Squibb News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapSuper Stock
    All News

    Brief: Fate Therapeutics Appoints Edward Dulac As Chief Financial Officer

    Picture of Bristol-Myers Squibb logoBristol-Myers Squibb
    19/08/2020 13:51
    Aug 19 (Reuters) - Fate Therapeutics Inc  FATE.O :
    * FATE THERAPEUTICS APPOINTS EDWARD DULAC AS CHIEF FINANCIAL
OFFICER
    * FATE THERAPEUTICS INC - DULAC COMES FROM CELGENE
CORPORATION,
WHERE HE MOST RECENTLY SERVED AS VICE PRESIDENT, BUSINESS
DEVELOPMENT & STRATEGY

Source text for Eikon:  ID:nGNX7Rb1d6 
Further company coverage:  FATE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Bristol-Myers Squibb

    See all news